We are thrilled to announce the launch of our Early Access to Mass Spectrometry services in Singapore, featuring our cutting-edge Rapid Data-Independent Acquisition (DIA) Proteomics services on Orbitrap Astral and Untargeted Metabolomics on Q Exactive HF-X platform.
Fill in the form below to indicate your interest in our Mass Spectrometry Early Access Programme.
Kickstart Your Multiomics Journey Today
Terms and Conditions*
• This promotion is valid from 1st December 2024 to 31st March 2025.
• This promotion is available exclusively for Singapore customer, with a minimum requirement of 12 samples, in a single batch.
• Peptide samples can be submitted starting December 2024.
• To qualify for the promotion, both the purchase order (PO) and samples must be received by 31st March 2025.
• Raw materials are accepted starting April 2025 but are excluded from this current promotion.
• The complimentary RNA-seq and metagenomics services cover library preparation and sequencing costs only. Costs for extraction and bioinformatic analysis are not included. Bioinformatic analysis can be separately arranged through your sales representative.
• The details of this promotion may be subjected to changes. NovogeneAIT Genomics reserves the right to interpret and modify these terms as necessary.
By registering on this page, you are consenting and agreeing for Novogene to contact you, assist with your request, and store your information per our privacy policy. You can change your email preferences at any time.
About NovogeneAT Genomics
NovogeneAIT Genomics is a leading multi-omics services and solutions provider headquartered in Singapore. It is formed as a strategic joint venture between Novogene and AITbiotech, a Singapore biotech Company in 2016. With an unwavering commitment to delivering high-quality, swift, and cost-effective omics solutions, NovogeneAIT Genomics has grown to become one of the largest NGS service providers in Southeast Asia. It offers a comprehensive suite of multi-omics services encompasses genomics, transcriptomics, single cell/spatial transcriptomics, metagenomics, and proteomics. Operating from our state-of-the-art sequencing center in Singapore, NovogeneAIT is dedicated to advancing genomic research by offering unmatched data quality that empowers researchers across diverse sectors, including healthcare and agriculture, to realize their research goals.
For more information, visit novogene.com/amea-en/.
For more information, visit novogene.com/amea-en/.
© 2024 Novogene Co., Ltd. All Rights Reserved
NovogeneAIT Genomics Pte. Ltd.
(Regional Office for Asia Pacific, Middle-East & Africa)
11 Biopolis Way, #10-11 Helios,
Singapore 138667
Novogene Japan K.K.
Kayabacho-Nagaoka BLDG3-7F, 2-7-10,
Nihonbashi-Kayabacho, Chuo City,
Tokyo,103-0025 Japan
Novogene (HK) Company Limited
Unit 1307, Everglory Centre,
1B Kimberly Street,
Tsim Sha Tsui, Hong Kong
1B Kimberly Street,
Tsim Sha Tsui, Hong Kong